Kendra L. Gully

5.8k total citations
12 papers, 991 citations indexed

About

Kendra L. Gully is a scholar working on Infectious Diseases, Animal Science and Zoology and Immunology. According to data from OpenAlex, Kendra L. Gully has authored 12 papers receiving a total of 991 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 3 papers in Animal Science and Zoology and 2 papers in Immunology. Recurrent topics in Kendra L. Gully's work include SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (6 papers) and Viral gastroenteritis research and epidemiology (4 papers). Kendra L. Gully is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (6 papers) and Viral gastroenteritis research and epidemiology (4 papers). Kendra L. Gully collaborates with scholars based in United States, China and South Africa. Kendra L. Gully's co-authors include Ralph S. Baric, Sarah R. Leist, Kenneth H. Dinnon, Yixuan J. Hou, Caitlin E. Edwards, Boyd L. Yount, Stephanie A. Montgomery, Alexandra Schäfer, Timothy P. Sheahan and Lisa E. Gralinski and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Kendra L. Gully

12 papers receiving 983 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kendra L. Gully United States 8 800 211 160 148 138 12 991
Olivia C. Swann United Kingdom 7 765 1.0× 206 1.0× 78 0.5× 144 1.0× 84 0.6× 7 929
Coralie Valle France 6 1.0k 1.3× 180 0.9× 127 0.8× 229 1.5× 137 1.0× 9 1.3k
Thomas Kuri Germany 10 841 1.1× 164 0.8× 257 1.6× 212 1.4× 247 1.8× 11 1.2k
Kangtai Liu China 6 636 0.8× 144 0.7× 66 0.4× 262 1.8× 109 0.8× 8 1.1k
Caitlin E. Edwards United States 11 859 1.1× 226 1.1× 158 1.0× 226 1.5× 172 1.2× 17 1.3k
Lok-Yin Roy Wong United States 13 579 0.7× 169 0.8× 104 0.7× 177 1.2× 215 1.6× 24 818
Xiaojing Dong China 9 790 1.0× 152 0.7× 99 0.6× 316 2.1× 431 3.1× 20 1.1k
Tiffany Tang United States 10 707 0.9× 85 0.4× 106 0.7× 249 1.7× 80 0.6× 12 912
Qiru Zeng China 5 559 0.7× 116 0.5× 63 0.4× 142 1.0× 90 0.7× 10 728

Countries citing papers authored by Kendra L. Gully

Since Specialization
Citations

This map shows the geographic impact of Kendra L. Gully's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kendra L. Gully with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kendra L. Gully more than expected).

Fields of papers citing papers by Kendra L. Gully

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kendra L. Gully. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kendra L. Gully. The network helps show where Kendra L. Gully may publish in the future.

Co-authorship network of co-authors of Kendra L. Gully

This figure shows the co-authorship network connecting the top 25 collaborators of Kendra L. Gully. A scholar is included among the top collaborators of Kendra L. Gully based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kendra L. Gully. Kendra L. Gully is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Boon, Adrianus C. M., Traci L. Bricker, Ethan J. Fritch, et al.. (2024). Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19. Journal of Virology. 98(5). e0190323–e0190323. 8 indexed citations
2.
Powers, John M., Sarah R. Leist, Michael L. Mallory, et al.. (2024). Divergent pathogenetic outcomes in BALB/c mice following Omicron subvariant infection. Virus Research. 341. 199319–199319. 1 indexed citations
3.
4.
Snouwaert, John N., Leigh A. Jania, Trang Thi Huyen Nguyen, et al.. (2023). Human ACE2 expression, a major tropism determinant for SARS-CoV-2, is regulated by upstream and intragenic elements. PLoS Pathogens. 19(2). e1011168–e1011168. 9 indexed citations
5.
Dinnon, Kenneth H., Sarah R. Leist, Alexandra Schäfer, et al.. (2021). Publisher Correction: A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures. Nature. 590(7844). E22–E22. 7 indexed citations
6.
Martinez, David R., Alexandra Schäfer, Sarah R. Leist, et al.. (2021). Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice. Cell Reports. 36(4). 109450–109450. 29 indexed citations
7.
8.
Shang, Jian, Yushun Wan, Chang Liu, et al.. (2020). Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry. PLoS Pathogens. 16(3). e1008392–e1008392. 105 indexed citations
9.
Dinnon, Kenneth H., Sarah R. Leist, Alexandra Schäfer, et al.. (2020). A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures. Nature. 586(7830). 560–566. 381 indexed citations
10.
Leist, Sarah R., Kenneth H. Dinnon, Alexandra Schäfer, et al.. (2020). A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice. Cell. 183(4). 1070–1085.e12. 332 indexed citations
11.
Dinnon, Kenneth H., Kendra L. Gully, Yixuan J. Hou, et al.. (2020). Swine acute diarrhea syndrome coronavirus replication in primary human cells reveals potential susceptibility to infection. UNC Libraries. 1 indexed citations
12.
Edwards, Caitlin E., Boyd L. Yount, Rachel L. Graham, et al.. (2020). Swine acute diarrhea syndrome coronavirus replication in primary human cells reveals potential susceptibility to infection. Proceedings of the National Academy of Sciences. 117(43). 26915–26925. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olivia C. Swann Breakdown of academic impact, for papers by Coralie Valle Breakdown of academic impact, for papers by Thomas Kuri Breakdown of academic impact, for papers by Kangtai Liu Breakdown of academic impact, for papers by Caitlin E. Edwards Breakdown of academic impact, for papers by Lok-Yin Roy Wong Breakdown of academic impact, for papers by Xiaojing Dong Breakdown of academic impact, for papers by Tiffany Tang Breakdown of academic impact, for papers by Qiru Zeng
Rankless by CCL
2026